Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF
Authors
Keywords
-
Journal
RESPIROLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-12-17
DOI
10.1111/resp.13753
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Closing the Evidence Gap in Interstitial Lung Disease: The Promise of Real World Data
- (2018) Erica Farrand et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report
- (2016) Harold R. Collard et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- (2015) Jonas Christian Schupp et al. PLoS One
- Epidemiologic Survey of Japanese Patients with Idiopathic Pulmonary Fibrosis and Investigation of Ethnic Differences
- (2014) Motoki Natsuizaka et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis
- (2014) Shinichiro Ohshimo et al. RESPIRATORY MEDICINE
- Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure
- (2013) K. A. Johannson et al. EUROPEAN RESPIRATORY JOURNAL
- Outcomes in idiopathic pulmonary fibrosis: A meta-analysis from placebo controlled trials
- (2013) C.P. Atkins et al. RESPIRATORY MEDICINE
- Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials
- (2013) Harold R Collard et al. RESPIRATORY RESEARCH
- Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
- (2013) Joyce S Lee et al. Lancet Respiratory Medicine
- Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- (2012) Dong Soon Kim CLINICS IN CHEST MEDICINE
- Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
- (2012) Marco Mura et al. EUROPEAN RESPIRATORY JOURNAL
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Features and Outcome of Acute Exacerbation of Interstitial Pneumonia: Collagen Vascular Diseases-Related versus Idiopathic
- (2011) Ryo Tachikawa et al. RESPIRATION
- Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography
- (2011) Hidemi Suzuki et al. SURGERY TODAY
- Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
- (2010) J. W. Song et al. EUROPEAN RESPIRATORY JOURNAL
- Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis
- (2009) Evans R. Fernández Pérez et al. CHEST
- Pirfenidone in idiopathic pulmonary fibrosis
- (2009) H. Taniguchi et al. EUROPEAN RESPIRATORY JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started